Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 4 2Phase 3 1

Status

Completed 17Unknown 3Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 92Breast Neoplasms 85Neoplasms 79Prostatic Neoplasms 50Lung Neoplasms 43Neoplasm Metastasis 40Colorectal Neoplasms 37Leukemia, Myeloid, Acute 32Pain 27Head and Neck Neoplasms 25Colonic Neoplasms 25Multiple Myeloma 24Ovarian Neoplasms 23Lymphoma 23Carcinoma, Hepatocellular 23Pancreatic Neoplasms 22Lymphoma, Follicular 21Melanoma 20Leukemia 20Rectal Neoplasms 19Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 17Recurrence 17Stomach Neoplasms 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Squamous Cell Carcinoma of Head and Neck 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leiomyoma 13Brain Neoplasms 13

Interventions

Venlafaxine Hydrochloride 1Sugars 1Soybean Proteins 1Isoflavones 1Caseins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Hot Flashes × Clear all
NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Wake Forest University Health Sciences

Phase 3 Terminated
120 enrolled 11 charts
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡